Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06083623
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of TNM001 for the Prevention of Lower Respiratory Tract Infection Caused by Respiratory Syncytial Virus in Infants

Who this might be right for
Respiratory Syncytial Virus Infections
Zhuhai Trinomab Pharmaceutical Co., Ltd. 2,282
Post-approval studies (Phase 4)Active Not RecruitingNCT07109297
What this trial is testing

Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India

Who this might be right for
RSV Immunization
Sanofi 110
Large-scale testing (Phase 3)Looking for participantsNCT05026749
What this trial is testing

Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children

Who this might be right for
Respiratory Syncytial Virus Infections
University of Alabama at Birmingham 370
Not applicableActive Not RecruitingNCT06077968
What this trial is testing

Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Disease

Who this might be right for
Respiratory Syncytial Viruses
Pfizer 1
Testing effectiveness (Phase 2)Study completedNCT01756482
What this trial is testing

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences 140
Not applicableActive Not RecruitingNCT06546800
What this trial is testing

SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER

Who this might be right for
Respiratory Syncytial Virus Infection
Pfizer 1,100
Not applicableActive Not RecruitingNCT07279298
What this trial is testing

Effectiveness of Immunization in Preventing Severe Acute Respiratory Infection RSV in Children Under 6 Months in Bogotá

Who this might be right for
Respiratory Syncytial Virus InfectionsSevere Acute Respiratory InfectionBronchiolitis, Viral+1 more
Bogotá District Health Secretariat 1,097
Early research (Phase 1)Study completedNCT05987072
What this trial is testing

Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.

Who this might be right for
Respiratory Syncytial Virus Infection
Pfizer 12
Early research (Phase 1)Active Not RecruitingNCT06645665
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd 240
Testing effectiveness (Phase 2)Study completedNCT01704365
What this trial is testing

RSV-F Vaccine Dose Ranging Study in Young Women

Who this might be right for
Respiratory Syncytial Virus (RSV)
Novavax 330
Large-scale testing (Phase 3)Study completedNCT05842967
What this trial is testing

Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV Disease

Who this might be right for
RESPIRATORY SYNCYTIAL VIRUS (RSV)
Pfizer 885
Not applicableActive Not RecruitingNCT07673081
What this trial is testing

Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos

Who this might be right for
Respiratory Syncytial Virus (RSV)
Pfizer 293,334
Testing effectiveness (Phase 2)Study completedNCT00240929
What this trial is testing

A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)

Who this might be right for
-Unhealthy Children With a History of Prematurity
MedImmune LLC 150
Not applicableUnknownNCT05550545
What this trial is testing

Infant RSV Infections and Health-related Quality of Life of Families

Who this might be right for
RSV InfectionQuality of LifeInfant ALL+2 more
Global Foundation for the Care of Newborn Infants 120
Not applicableLooking for participantsNCT07239583
What this trial is testing

Genotype and Disease Burden of RSV in Older Vietnamese Adults (RSV: Respiratory Syncytial Virus )

Who this might be right for
Respiratory Syncytial Virus InfectionRespiratory Syncytial Virus Infections
Tam Anh Research Institute 1,000
Testing effectiveness (Phase 2)Ended earlyNCT04056611
What this trial is testing

Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Sciences Ireland UC 3
Early research (Phase 1)Study completedNCT07071558
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age

Who this might be right for
Respiratory Syncytial Virus Immunization
Sanofi 240
Early research (Phase 1)Study completedNCT01875926
What this trial is testing

ALX-0171 Phase I Pharmacokinetic Study in Healthy Male Volunteers

Who this might be right for
HealthyRSV Infection
Ablynx, a Sanofi company 44
Not applicableUnknownNCT04531735
What this trial is testing

Respiratory Syncytial Virus Infection May be More Dangerous in Neonate

Who this might be right for
RSV InfectionCovid19
Dr. Behcet Uz Children's Hospital 28
Large-scale testing (Phase 3)Study completedNCT00121108
What this trial is testing

MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States

Who this might be right for
Healthy
MedImmune LLC 2,127
Next Page